• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Warby Parker Inc.

    5/6/25 5:07:56 PM ET
    $WRBY
    Ophthalmic Goods
    Health Care
    Get the next $WRBY alert in real time by email
    DEFA14A 1 tm2514072-3_defa14a.htm DEFA14A tm2514072-3_defa14a - none - 3.2031423s
    ​
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    SCHEDULE 14A
    (Rule 14a-101)
    INFORMATION REQUIRED IN PROXY STATEMENT
    SCHEDULE 14A INFORMATION
    Proxy Statement Pursuant to Section 14(a) of the
    Securities Exchange Act of 1934 (Amendment No. 1)
    ​ Filed by the Registrant   ☒ ​ ​ Filed by a Party other than the Registrant   ☐ ​
    Check the appropriate box:
    ☐
    Preliminary Proxy Statement
    ​
    ☐
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ​
    ☐
    Definitive Proxy Statement
    ​
    ☒
    Definitive Additional Materials
    ​
    ☐
    Soliciting Material under §240.14a-12
    ​
    WARBY PARKER INC.
    (Name of Registrant as Specified in its Charter)
    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)​
    Payment of Filing Fee (Check all boxes that apply):
    ☒
    No fee required.
    ​
    ☐
    Fee paid previously with preliminary materials.
    ​
    ☐
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
    ​

    ​
    Amendment to Definitive Proxy Statement for the
    2025 Annual Meeting of Stockholders
    June 10, 2025
    EXPLANATORY NOTE
    This Proxy Statement Amendment, dated May 6, 2025 (this “Amendment”), amends the Definitive Proxy Statement of Warby Parker Inc., a Delaware public benefit corporation (the “Company”), filed with the Securities and Exchange Commission on April 28, 2025 (the “Proxy Statement”), relating to the Annual Meeting of Stockholders of the Company to be held on June 10, 2025 via live webcast.
    The purpose of this Amendment is to correct an error regarding the number of shares of Class B common stock held by Neil Blumenthal, as reported in the beneficial ownership table included on pages 45 and 46 of the Proxy Statement under the heading “Security Ownership of Certain Beneficial Owners and Management”.
    Accordingly, the Proxy Statement disclosure under the heading “Security Ownership of Certain Beneficial Owners and Management” is amended and restated in its entirety with the following disclosure. No other changes have been made to the Proxy Statement.

    ​
    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
    The following table sets forth information with respect to the beneficial ownership of our Common Stock for:
    ●
    each person known by us to beneficially own more than 5% of our Common Stock;
    ​
    ●
    each of our directors;
    ​
    ●
    each of our NEOs; and
    ​
    ●
    all of our executive officers and directors as a group.
    ​
    The number of shares beneficially owned by each stockholder as described in this proxy statement is determined under rules issued by the SEC. Under these rules, beneficial ownership includes any shares as to which the individual or entity has sole or shared voting power or investment power. In computing the number of shares beneficially owned by an individual or entity and the percentage ownership of that person, shares of Common Stock subject to options, or other rights held by such person that are currently exercisable or will become exercisable within 60 days of April 14, 2025, are considered outstanding, although these shares are not considered outstanding for purposes of computing the percentage ownership of any other person. Applicable percentage ownership is based on 104,502,616 shares of Class A common stock and 16,903,698 shares of Class B common stock outstanding as of April 14, 2025. “Percentage of Total Voting Power” represents voting power with respect to all outstanding shares of our Class A common stock and Class B common stock, as a single class, as of April 14, 2025. The holders of our Class B common stock are entitled to 10 votes per share, and holders of our Class A common stock are entitled to one vote per share. Unless otherwise indicated, the address of all listed stockholders is 233 Spring Street, 6th Floor East, New York, New York 10013.
    Each of the stockholders listed has sole voting and investment power with respect to the shares beneficially owned by the stockholder unless noted otherwise, subject to community property laws where applicable.
    ​ ​ ​
    Class A Common Stock
    ​ ​
    Class B Common Stock
    ​ ​
    Percentage
    of
    Total Voting
    Power
    ​
    Name and Address of Beneficial Owner
    ​ ​
    Shares
    ​ ​
    %
    ​ ​
    Shares
    ​ ​
    %
    ​
    5% or Greater Stockholders ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
    The Vanguard Group(1)
    ​ ​ ​ ​ 10,139,563 ​ ​ ​ ​ ​ 9.7 ​ ​ ​
    —
    ​ ​
    —
    ​ ​ ​ ​ 3.7 ​ ​
    Durable Capital Partners LP(2)
    ​ ​ ​ ​ 8,177,028 ​ ​ ​ ​ ​ 7.8 ​ ​ ​
    —
    ​ ​
    —
    ​ ​ ​ ​ 3.0 ​ ​
    FMR LLC(3)
    ​ ​ ​ ​ 6,668,586 ​ ​ ​ ​ ​ 6.4 ​ ​ ​
    —
    ​ ​
    —
    ​ ​ ​ ​ 2.4 ​ ​
    Blackrock Inc.(4)
    ​ ​ ​ ​ 6,601,034 ​ ​ ​ ​ ​ 6.3 ​ ​ ​
    —
    ​ ​
    —
    ​ ​ ​ ​ 2.4 ​ ​
    D1 Capital Partners L.P. and affiliates(5)
    ​ ​ ​ ​ 5,289,014 ​ ​ ​ ​ ​ 5.1 ​ ​ ​
    —
    ​ ​
    —
    ​ ​ ​ ​ 1.9 ​ ​
    Named Executive Officers and Directors ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
    Neil Blumenthal(6)
    ​ ​ ​ ​ 433,777 ​ ​ ​
    * 
    ​ ​ ​ ​ 8,375,216 ​ ​ ​ ​ ​ 47.4 ​ ​ ​ ​ ​ 29.9 ​ ​
    David Gilboa(7)
    ​ ​ ​ ​ 33,905 ​ ​ ​
    * 
    ​ ​ ​ ​ 7,809,083 ​ ​ ​ ​ ​ 44.2 ​ ​ ​ ​ ​ 27.8 ​ ​
    Steven Miller(8)
    ​ ​ ​ ​ 322,854 ​ ​ ​
    * 
    ​ ​
    —
    ​ ​
    —
    ​ ​
    *
    ​
    Andrew Hunt
    ​ ​ ​ ​ 1,913,205 ​ ​ ​ ​ ​ 1.8 ​ ​ ​
    —
    ​ ​
    —
    ​ ​
    *
    ​
    Jeffrey Raider(9)
    ​ ​ ​ ​ 4,186,697 ​ ​ ​ ​ ​ 4.0 ​ ​ ​
    —
    ​ ​
    —
    ​ ​ ​ ​ 1.5 ​ ​
    Teresa Briggs(10)
    ​ ​ ​ ​ 54,828 ​ ​ ​
    * 
    ​ ​
    —
    ​ ​
    —
    ​ ​
    *
    ​
    Joel Cutler(11)
    ​ ​ ​ ​ 245,072 ​ ​ ​
    * 
    ​ ​
    —
    ​ ​
    —
    ​ ​
    *
    ​
    Youngme Moon
    ​ ​ ​ ​ 86,942 ​ ​ ​
    * 
    ​ ​
    —
    ​ ​
    —
    ​ ​
    *
    ​
    Bradley Singer(12)
    ​ ​ ​ ​ 140,793 ​ ​ ​
    * 
    ​ ​
    —
    ​ ​
    —
    ​ ​
    *
    ​
    Ronald A. Williams(13)
    ​ ​ ​ ​ 92,434 ​ ​ ​
    * 
    ​ ​
    —
    ​ ​
    —
    ​ ​
    *
    ​
    All directors and executive officers as a group (10 individuals)(14)
    ​ ​ ​ ​ 7,510,507 ​ ​ ​ ​ ​ 7.2 ​ ​ ​ ​ ​ 16,184,299 ​ ​ ​ ​ ​ 87.9 ​ ​ ​ ​ ​ 58.6 ​ ​
    ​
    *
    Less than one percent.
    ​
    (1)
    Based solely on a Schedule 13G/A filed with the SEC on September 10, 2024. The Vanguard Group reports shared voting power over 158,582 shares of Class A common stock, sole dispositive power over 9,901,971 shares of Class A common stock, and shared dispositive power over 237,592 shares of Class A common stock. The address of the Vanguard Group is 100 Vanguard Blvd. Malvern, PA 19355.
    ​
    (2)
    Based solely on a Schedule 13G/A filed with the SEC on November 14, 2024. Consists of shares of Class A common stock over which Durable Capital Partners LP (“Durable LP”), as the investment adviser to Durable Capital Master Fund LP, exercises sole
    ​

    ​
    voting and dispositive power. Durable Capital Partners GP LLC (“Durable GP”) is the general partner of the Durable LP, and Henry Ellenbogen is the chief investment officer of the Durable LP and the managing member of Durable GP. The address of Durable LP is 4747 Bethesda Avenue, Suite 1002, Bethesda, Maryland 20814.
    (3)
    Based solely on a Schedule 13G/A filed with the SEC on November 12, 2024. FMR LLC reports sole voting power over 6,440,917 shares of Class A common stock and sole dispositive power over 6,668,586 shares of Class A common stock. Abigail P. Johnson is a director, chairman and chief executive officer of FMR LLC and has sole dispositive power over 6,668,586 shares of Class A common stock. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders’ voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders’ voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of FMR LLC is 245 Summer Street, Boston, MA 02210.
    ​
    (4)
    Based solely on a Schedule 13G/A filed with the SEC on April 17, 2025. BlackRock, Inc. reports sole voting power over 6,492,140 shares of Class A common stock and sole dispositive power over 6,601,034 shares of Class A common stock. The address of BlackRock, Inc. is 50 Hudson Yards, New York, NY 10001.
    ​
    (5)
    Based solely on a Schedule 13G/A filed with the SEC on February 14, 2025. Consists of (i) 5,261,814 shares of Class A common stock over which D1 Capital Partners L.P. (the “Investment Manager”) and Daniel Sundheim exercise shared voting and dispositive power, and (ii) 27,200 shares of Class A common stock over which Daniel Sundheim exercises sole voting and dispositive power. The Investment Manager is a registered investment adviser and serves as the investment manager of private investment vehicles and accounts, including D1 Capital Partners Master LP (the “Investment Vehicle”), and may be deemed to beneficially own the shares of Class A common stock held by the Investment Vehicle and/or its subsidiary. Mr. Sundheim indirectly controls the Investment Manager and may be deemed to beneficially own the shares of Class A common stock held by the Investment Vehicle and/or its subsidiary. The address of the Investment Manager and Daniel Sundheim is 9 West 57th Street, 36th Floor, New York, New York 10019.
    ​
    (6)
    Consists of (i) 23,961 shares of Class A common stock, (ii) 400,000 shares of Class A common stock held by various family trusts over which Mr. Blumenthal may be deemed to have shared voting and dispositive power, (iii) 4,486,262 shares of Class B common stock, (iv) 3,133,555 shares of Class B common stock held by various family trusts over which Mr. Blumenthal may be deemed to have shared voting and dispositive power, (v) 9,816 shares of Class A common stock underlying RSUs that vest within 60 days of April 14, 2025, (vi) 44,640 shares of Class B common stock underlying RSUs that vest within 60 days of April 14, 2025, and (vii) 710,759 shares of Class B common stock underlying options that are exercisable within 60 days of April 14, 2025. Mr. Blumenthal has pledged 3,039,763 shares of Class B common stock beneficially owned by him pursuant to a line of credit note with customary default provisions as security in favor of JPMorgan Chase Bank, N.A. See “Certain Relationships and Related Party Transactions—Issuer Agreements.”
    ​
    (7)
    Consists of (i) 24,089 shares of Class A common stock, (ii) 5,396,914 shares of Class B common stock, (iii) 1,656,770 shares of Class B common stock held by a family trust over which Mr. Gilboa may be deemed to have shared voting and dispositive power, (iv) 9,816 shares of Class A common stock underlying RSUs that vest within 60 days of April 14, 2025, (v) 44,640 shares of Class B common stock underlying RSUs that vest within 60 days of April 14, 2025, and (vi) 710,759 shares of Class B common stock underlying options that are exercisable within 60 days of April 14, 2025. Mr. Gilboa has pledged 3,177,224 shares of Class B common stock beneficially owned by him pursuant to a line of credit note with customary default provisions as security in favor of JPMorgan Chase Bank, N.A. See “Certain Relationships and Related Party Transactions—Issuer Agreements.”
    ​
    (8)
    Consists of (i) 204,727 shares of our Class A common stock, (ii) 30,175 shares of Class A common stock underlying RSUs that vest within 60 days of April 14, 2025, and (iii) 87,952 shares of Class A common stock underlying options that are exercisable within 60 days of April 14, 2025.
    ​
    (9)
    Consists of (i) 496,465 shares of our Class A common stock and (ii) 3,690,232 shares of our Class A common stock held by various trusts over which Mr. Raider may be deemed to have shared voting and dispositive power.
    ​
    (10)
    Consists of (i) 38,859 shares of our Class A common stock and (ii) 15,969 shares of Class A common stock held by a trust over which Ms. Briggs may be deemed to have shared voting and dispositive power.
    ​
    (11)
    Consists of 245,072 shares of Class A common stock held by various family trusts of which Mr. Cutler and his spouse serve as trustees and, therefore, over which Mr. Cutler may be deemed to have voting and investment control.
    ​
    (12)
    Consists of (i) 15,793 shares of our Class A common stock and (ii) 125,000 shares of Class A common stock held by a trust over which Mr. Singer may be deemed to have shared voting and dispositive power.
    ​
    (13)
    Consists of 83,261 shares of our Class A common stock and (ii) 9,173 shares of Class A common stock held by a trust over which Mr. Williams may be deemed to have shared voting and dispositive power.
    ​
    (14)
    Consists of (i) 7,372,748 shares of Class A common stock held by all directors and executive officers of the Company as a group, (ii) 49,807 shares of Class A common stock underlying RSUs held by all directors and executive officers of the Company as a group and that vest within 60 days of April 14, 2025, (iii) 87,952 shares of Class A common stock underlying options held by all directors and executive officers of the Company as a group and that are exercisable within 60 days of April 14, 2025, (iv) 14,673,501 shares of Class B common stock held by all directors and executive officers of the Company as a group, (v) 89,280 shares of Class B common stock underlying RSUs held by all directors and executive officers of the Company as a group that vest within 60 days of April 14, 2025, and (vi) 1,421,518 shares of Class B common stock underlying options held by all directors and executive officers of the Company as a group and that are exercisable within 60 days of April 14, 2025.
    ​
    ***

    ​
    Prior to the Annual Meeting, you may vote your shares or revoke your previously submitted proxy. For additional information, please refer to the Company’s Definitive Proxy Statement which was filed with the Securities and Exchange Commission on April 28, 2025. IF YOU HAVE ALREADY VOTED AND DO NOT WISH TO CHANGE YOUR VOTE, YOU DO NOT NEED TO DO ANYTHING. YOUR VOTE WILL BE TABULATED AS YOU INSTRUCTED AT THE ANNUAL MEETING.

    Get the next $WRBY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WRBY

    DatePrice TargetRatingAnalyst
    4/30/2025$17.00Sell → Neutral
    Citigroup
    4/17/2025$27.00Hold → Buy
    Loop Capital
    2/28/2025$28.00 → $30.00Outperform
    Telsey Advisory Group
    2/25/2025$26.00Neutral
    ROTH MKM
    2/5/2025$19.00 → $23.00Neutral → Sell
    Citigroup
    1/17/2025$23.00Outperform → In-line
    Evercore ISI
    11/19/2024$22.00 → $26.00Outperform
    Telsey Advisory Group
    11/8/2024$19.00 → $22.00Outperform
    Telsey Advisory Group
    More analyst ratings

    $WRBY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Warby Parker Announces First Quarter 2025 Results

      Net revenue increased 12% year over year to $224 million Active Customers increased 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2025. "Our team delivered a strong start to 2025. We opened 11 net new stores, exceeded profitability expectations, drove the highest e-commerce growth we've seen since 2021, and delivered our seventh consecutive quarter of accelerating active customer growth," shared Co-Founder and Co-CEO Neil Blumenthal. "Looking to the rest of the year, we'll leverage our diversified suppl

      5/8/25 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2025 will be released before market open on May 8, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 020310. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentation

      4/17/25 4:05:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Target and Warby Parker Team Up to Bring Stylish, Affordable Eyewear to More Consumers

      New Warby Parker at Target shop-in-shops will offer guests designer-quality eyewear as well as contacts and eye exams Five shop-in-shops will debut in 2025 with plans to open more in the years aheadMINNEAPOLIS and NEW YORK, Feb. 27, 2025 /PRNewswire/ -- Target Corporation (NYSE:TGT) and Warby Parker (NYSE:WRBY) are partnering to bring designer-quality, affordable eyewear to even more consumers through the retailer's newest shop-in-shop, Warby Parker at Target. Each Warby Parker at Target shop-in-shop will offer products and services — including glasses, sunglasses, contacts, e

      2/27/25 7:15:00 AM ET
      $TGT
      $WRBY
      Department/Specialty Retail Stores
      Consumer Discretionary
      Ophthalmic Goods
      Health Care

    $WRBY
    Leadership Updates

    Live Leadership Updates

    See more
    • Warby Parker appoints Ronald A. Williams as Lead Director and welcomes Bradley E. Singer to Board of Directors

      Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company") announced today the appointment of Ron Williams as Lead Director. "Ron's deep expertise in transformational leadership is helping Warby Parker lead the way in making the optical industry more customer and patient friendly. Our shareholders and our team are lucky to have such an exceptional and experienced leader as our first Lead Director," said Neil Blumenthal, co-Founder and co-CEO. The Company has also appointed a new independent director, Brad Singer, to its board of directors. Mr. Singer's appointment is effective today, August 1, 2024. "Brad brings a wealth of experience as a dynamic operator and investor," said Dav

      8/1/24 4:15:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Singer Bradley E bought $965,750 worth of shares (75,000 units at $12.88) (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      8/14/24 4:52:02 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    SEC Filings

    See more
    • SEC Form 10-Q filed by Warby Parker Inc.

      10-Q - Warby Parker Inc. (0001504776) (Filer)

      5/8/25 5:10:13 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Warby Parker Inc. (0001504776) (Filer)

      5/8/25 6:46:05 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • SEC Form DEFA14A filed by Warby Parker Inc.

      DEFA14A - Warby Parker Inc. (0001504776) (Filer)

      5/6/25 5:07:56 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    Financials

    Live finance-specific insights

    See more
    • Warby Parker Announces First Quarter 2025 Results

      Net revenue increased 12% year over year to $224 million Active Customers increased 9% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the first quarter ended March 31, 2025. "Our team delivered a strong start to 2025. We opened 11 net new stores, exceeded profitability expectations, drove the highest e-commerce growth we've seen since 2021, and delivered our seventh consecutive quarter of accelerating active customer growth," shared Co-Founder and Co-CEO Neil Blumenthal. "Looking to the rest of the year, we'll leverage our diversified suppl

      5/8/25 6:45:00 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025

      Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2025 will be released before market open on May 8, 2025. In addition, the Company will discuss its results and business outlook during a live conference call and webcast at 8:00 a.m. Eastern Time. The conference call can be accessed by dialing 833-470-1428 from the U.S. or 404-975-4839 from international locations. The conference passcode is 020310. A live webcast of the conference call will be available on the investors section of the Company's website at investors.warbyparker.com where presentation

      4/17/25 4:05:00 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker Announces Fourth Quarter and Full Year 2024 Results

      Q4 net revenue increased 17.8% year over year; 2024 net revenue increased 15.2% year over year Active Customers increased 7.8% on a trailing 12-month basis Warby Parker Inc. (NYSE:WRBY) ("Warby Parker" or the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the fourth quarter and full year ended December 31, 2024. "Our strong 2024 results highlight the power of Warby Parker's brand and unmatched value proposition combined with our team's high-quality execution. We delivered on our ambitious goals to accelerate revenue growth, customer growth and glasses growth, all while maintaining operational discipline and expanding p

      2/27/25 6:45:00 AM ET
      $TGT
      $WRBY
      Department/Specialty Retail Stores
      Consumer Discretionary
      Ophthalmic Goods
      Health Care

    $WRBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      11/14/24 5:08:23 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      11/14/24 1:30:16 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Warby Parker Inc.

      SC 13G/A - Warby Parker Inc. (0001504776) (Subject)

      11/12/24 10:40:28 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Warby Parker upgraded by Citigroup with a new price target

      Citigroup upgraded Warby Parker from Sell to Neutral and set a new price target of $17.00

      4/30/25 1:18:55 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Warby Parker upgraded by Loop Capital with a new price target

      Loop Capital upgraded Warby Parker from Hold to Buy and set a new price target of $27.00

      4/17/25 8:27:42 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Telsey Advisory Group reiterated coverage on Warby Parker with a new price target

      Telsey Advisory Group reiterated coverage of Warby Parker with a rating of Outperform and set a new price target of $30.00 from $28.00 previously

      2/28/25 8:48:26 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care

    $WRBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cutler Joel E disposed of 5,656,571 shares (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/18/25 9:52:05 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Chief Financial Officer Miller Steven Clive sold $274,808 worth of shares (11,684 units at $23.52), was granted 15,128 shares, covered exercise/tax liability with 6,321 shares and converted options into 27,731 shares, increasing direct ownership by 14% to 204,727 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/6/25 6:02:10 AM ET
      $WRBY
      Ophthalmic Goods
      Health Care
    • Co-Chief Executive Officer Gilboa David Abraham converted options into 3,271 shares, sold $4,772,513 worth of shares (202,968 units at $23.51), was granted 23,250 shares, covered exercise/tax liability with 12,858 shares and converted options into 201,088 shares, increasing direct ownership by 96% to 24,089 units (SEC Form 4)

      4 - Warby Parker Inc. (0001504776) (Issuer)

      3/5/25 9:57:41 PM ET
      $WRBY
      Ophthalmic Goods
      Health Care